Caspofungin in Combination with Amphotericin B against Candida glabrata
- 1 June 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (6) , 2546-9
- https://doi.org/10.1128/aac.49.6.2546-2549.2005
Abstract
The effects of caspofungin combined with amphotericin B were investigated with Candida glabrata . Although in vitro experiments showed an indifferent interaction, the combination regimen was the only therapeutic approach yielding organ sterilization in a murine candidemia model.Keywords
This publication has 8 references indexed in Scilit:
- Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002Journal of Clinical Microbiology, 2004
- Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for StandardizationClinical Microbiology Reviews, 2004
- Combination Antifungal TherapyAntimicrobial Agents and Chemotherapy, 2004
- CaspofunginClinical Infectious Diseases, 2003
- Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicansJournal of Antimicrobial Chemotherapy, 2003
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year AnalysisClinical Infectious Diseases, 1999
- Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)Clinical Infectious Diseases, 1999
- Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicansClinical Microbiology Reviews, 1999